Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 16, 1986 - Issue 5
12
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The metabolism of debrisoquine in man: (1) Regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis

, , , &
Pages 503-509 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

T. Lightfoot, S. W. Ellis, J. Mahling, M. J. Ackland, F. E. Blaney, G. J. Bijloo, M. J. De Groot, N. P. E. Vermeulen, G. M. Blackburn, M. S. Lennard & G. T. Tucker. (2000) Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling. Xenobiotica 30:3, pages 219-233.
Read now
A. G. Renwick. (1993) Data‐derived safety factors for the evaluation of food additives and environmental contaminants. Food Additives & Contaminants 10:3, pages 275-305.
Read now
A. G. Renwick. (1991) Safety factors and establishment of acceptable daily intakes. Food Additives & Contaminants 8:2, pages 135-149.
Read now

Articles from other publishers (4)

Vivien M. Hodges, Gael Y. Molloy & Wickramasinghe. (2001) Demonstration of mRNA for five species of cytochrome P450 in human bone marrow, bone marrow‐derived macrophages and human haemopoietic cell lines. British Journal of Haematology 108:1, pages 151-156.
Crossref
A.G. Renwick & N.R. Lazarus. (1998) Human Variability and Noncancer Risk Assessment— An Analysis of the Default Uncertainty Factor. Regulatory Toxicology and Pharmacology 27:1, pages 3-20.
Crossref
P. K. Kunicki, D. Sitkiewicz, E. Borowiecka, A. Pawlik, B. Gawrońska-Szklarz, R. Sterna, V. Bielicka-Sulzyc, H. Matsumoto & M. Radziwoń-Zaleska. (1995) Debrisoquine hydroxylation in a Polish population. European Journal of Clinical Pharmacology 47:6, pages 503-505.
Crossref
M. E. Veronese & S. McLean. (1991) Debrisoquine oxidation polymorphism in a Tasmanian population. European Journal of Clinical Pharmacology 40:5, pages 529-532.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.